source

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…

3 months ago

Altai Provides Update on Quebec Litigation

September 05, 2025 18:39 ET  | Source: Altai Resources Inc. TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc.…

3 months ago

Enovix Announces Completion of Warrant Dividend Program

September 05, 2025 18:08 ET  | Source: Enovix Corporation Warrants Expired and Ceased Trading on Friday, August 29, 2025 Approximately…

3 months ago

Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta

September 05, 2025 16:45 ET  | Source: Helios Alliance Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance,…

3 months ago

LEADING EUROPEAN PAYMENT PROVIDER, SIBS, SELECTS GEP’S PROCUREMENT SOFTWARE TO MANAGE SOURCE TO CONTRACT GLOBALLY AND DRIVE NEW VALUE

The Portuguese-based company, which operates in more than 25 countries across the world, will use GEP SMART to support its entire…

4 months ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

September 04, 2025 20:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05,…

4 months ago

Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes

September 03, 2025 21:47 ET  | Source: Mesoblast Limited NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

4 months ago

Cribl is Named to the 2025 Forbes Cloud 100

Observability leader ranked among the world’s best private cloud companies for third consecutive year September 03, 2025 11:00 ET  |…

4 months ago

BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected

Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the…

4 months ago

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

September 02, 2025 21:33 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

4 months ago